Renal osteodystrophy in pre-dialysis patients: ethnic difference?

• Published in: Peritoneal dialysis international 1999-01, Vol.19 Suppl 2 (2_suppl), p.S402-407
• Main Authors: Shin, S K, Kim, D H, Kim, H S, Shin, K T, Ma, K A, Kim, S J, Kwak, Y S, Ha, S K, Sherrard, D J
• Format: Article
• Language: English
• Subjects: Adult; Aged; Asian Continental Ancestry Group; Bone and Bones - metabolism; Bone and Bones - pathology; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder - ethnology; Chronic Kidney Disease-Mineral and Bone Disorder - metabolism; Chronic Kidney Disease-Mineral and Bone Disorder - pathology; Deferoxamine; European Continental Ancestry Group; Female; Humans; Korea; Male; Middle Aged; Parathyroid Hormone - blood; Peritoneal Dialysis; Renal Dialysis
• ISSN: 0896-8608; 1718-4304
• DOI: 10.1177/089686089901902s65

The purpose of the present study is to investigate whether an ethnic difference exists in the incidence of renal osteodystrophy between Asian and Western countries in end-stage renal disease (ESRD) patients. We evaluated bone histology in 58 pre-dialysis patients (28 male, 30 female; mean age: 47.7 years). All patients had bone biopsies with quantitative histomorphometry and serological parameters such as intact PTH, osteocalcin, total alkaline phosphatase, and basal and deferoxamine-stimulated serum aluminum levels. We observed that 91.4% of all evaluated patients showed renal osteodystrophy before the start of dialytic therapy. Mild osteitis fibrosa were observed in 21 patients (36.2%), severe osteitis fibrosa in 5 patients (8.6%), mixed lesions in 7 patients (12.1%), osteomalacia in 6 patients (10.3%), aplastic bone disease in 14 patients (24.1%), and normal bone in 5 patients (8.6%). Among the bone histomorphometric parameters, fibrosis area rate (%) showed the best correlation with intact PTH, and osteocalcin and osteoid area rate (%) with total alkaline phosphatase. Aluminum-related bone disease was not observed. Among patients with aplastic bone disease, only 14.3% showed aluminum deposition of any significance (5% < stainable bone surface aluminum < 25%). In the diabetic patients, aplastic bone disease was most common, but no case was related to aluminum intoxication. In conclusion, the distribution of renal osteodystrophy in our study was different from that of Western countries in pre-dialysis patients. Our patients tended to have more mild-form osteitis fibrosa and normal findings, and less severe-form osteitis fibrosa and aplastic bone disease. Aluminum-related bone disease was not observed.